Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China
Liver International · 2024
DOI: 10.1111/liv.16002 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Liver International, 2024. Verfasst von Yu Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Hypertension, Portal, gamma-Glutamyltransferase, Esophageal and Gastric Varices, Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Jiangsu Commission of Health, Jiangsu Province Postgraduate Research and Practice Innovation Plan Project.
Abstract (Originalsprache)
Background and Aims Porto‐sinusoidal vascular disease (PSVD) is an under‐recognized and under‐diagnosed disease. The purpose of this study was to investigate the clinical features and prognosis of PSVD.
Methods
The patients who underwent liver biopsies were analyzed retrospectively. The clinical and pathological data were reviewed and screened according to the latest diagnostic criteria of PSVD.
Results
A total of 234 patients were diagnosed as PSVD, including 103 patients presented with portal hypertension (PH) and 131 patients without PH. At baseline, the alanine aminotransferase (ALT) and γ‐glutamyl transpeptidase (GGT) levels were higher in the no‐PH group. The liver stiffness increased in the PH group. In histological review, obliterative portal venopathy, sinusoidal dilatation and architectural disturbance were more common in the PH group, while portal tract abnormalities were more widely distributed in the no‐PH group. After a median follow‐up of 43.6 months, the survival rate of patients with baseline liver decompensation was 76.0%, and that of patients at a liver compensated stage in the PH group was 98.7%. First variceal bleeding occurred in 13.8% of patients with gastric‐oesophageal varices. None of the patients in the no‐PH group developed portal hypertension during follow‐up.
Conclusions
PSVD can manifest as PH or mild liver enzyme abnormalities. There are significant differences in pathological features among patients with different clinical manifestations. Recurrent ascites are the main cause of death in PSVD patients. However, patients without PH have a slow disease progression, with recurrent elevated GGT levels being their main clinical feature.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Southeast University, Nanjing, China.
- The Second Hospital of Nanjing, Teaching Hospital of Southeast University, Nanjing, China.
- Department of Liver Diseases, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Pathology, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
- Department of Infectious Disease and Liver Disease, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China.
ORCID-Profile: Yu Zhang, Li Wang, Yongfeng Yang
Förderung
- Jiangsu Commission of Health
- Jiangsu Province Postgraduate Research and Practice Innovation Plan Project
Zitieren
APA
Zhang, Y., Xiong, Q., Zhong, Y., Liu, D., Liu, H., Wang, L., Du, Z., Chen, M., Zheng, Y., & Yang, Y. (2024). Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China. Liver International. https://doi.org/10.1111/liv.16002
Vancouver
Zhang Y, Xiong Q, Zhong Y, Liu D, Liu H, Wang L, et al. Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China. Liver International. 2024. doi:10.1111/liv.16002
BibTeX
@article{Zhang2024,
author = {Zhang, Yu and Xiong, Qingfang and Zhong, Yandan and Liu, Duxian and Liu, Hongli and Wang, Li and Du, Zhixiang and Chen, Miaoyang and Zheng, Yufeng and Yang, Yongfeng},
title = {Clinical characteristics and natural history of porto‐sinusoidal vascular disease: A cohort study of 234 patients in China},
journal = {Liver International},
year = {2024},
doi = {10.1111/liv.16002}
}
EUVIMED